AC
ABBV icon

Athanor Capital’s AbbVie ABBV Stock Holding History

Athanor Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,193
Closed -$778K – 431
2021
Q1 		$778K Sell
7,193
-3,495
-33% -$374K 0.02% 394
2020
Q4 		$1.15M Buy
10,688
+5,785
+118% +$556K 0.03% 287
2020
Q3 		$429K Buy
4,903
+2,610
+114% +$246K 0.02% 362
2020
Q2 		$225K Buy
+2,293
New +$202K 0.01% 474

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Athanor Capital's ABBV Position: Q2 2021 in Review

Athanor Capital sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 7,193 shares — an estimated $778K sold.

Athanor Capital first reported a position in ABBV in Q2 2020 and held it in 4 quarters. The position peaked at $1.15M in Q4 2020. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Athanor Capital reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 7,193 AbbVie shares in Q2 2021, an estimated $778K.
  • Athanor Capital first reported a position in AbbVie in Q2 2020 and held it in 4 quarters.
  • Athanor Capital's AbbVie position peaked at $1.15M in Q4 2020.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.